Yang Y, Cai Z, Zhang J (2021) Insulin treatment may increase adverse outcomes in patients with COVID-19 and diabetes: a systematic review and meta-analysis. Front Endocrinol (Lausanne) 12:696087. https://doi.org/10.3389/fendo.2021.696087

Article  Google Scholar 

Shestakova MV, Vikulova OK, Elfimova AR, Deviatkin AA, Dedov II, Mokrysheva NG (2022) Risk factors for COVID-19 case fatality rate in people with type 1 and type 2 diabetes mellitus: a nationwide retrospective cohort study of 235,248 patients in the Russian Federation. Front Endocrinol (Lausanne) 13:909874. https://doi.org/10.3389/fendo.2022.909874

Article  CAS  Google Scholar 

Mustroph J, Hupf J, Hanses F, Evert K, Baier MJ, Evert M et al (2021) Decreased GLUT1/NHE1 RNA expression in whole blood predicts disease severity in patients with COVID-19. ESC Heart Fail 8:309–316. https://doi.org/10.1002/ehf2.13063

Article  PubMed  Google Scholar 

Cure MC, Cure E (2022) Prolonged NHE activation may be both cause and outcome of cytokine release syndrome in COVID-19. Curr Pharm Des 28:1815–1822. https://doi.org/10.2174/1381612828666220713121741

Article  PubMed  Google Scholar 

Kaloyianni M, Bourikas D, Koliakos G (2001) The effect of insulin on Na+-H+ antiport activity of obese and normal subjects erythrocytes. Cell Physiol Biochem 11:253–258. https://doi.org/10.1159/000047811

Article  PubMed  CAS  Google Scholar 

He P, Zhao L, Zhu L, Weinman EJ, De Giorgio R, Koval M et al (2015) Restoration of Na+/H+ exchanger NHE3-containing macrocomplexes ameliorates diabetes-associated fluid loss. J Clin Invest 125:3519–3531. https://doi.org/10.1172/JCI79552

Article  PubMed  PubMed Central  Google Scholar 

Gangadharan C, Ahluwalia R, Sigamani A (2021) Diabetes and COVID-19: role of insulin resistance as a risk factor for COVID-19 severity. World J Diabetes 12:1550–1562. https://doi.org/10.4239/wjd.v12.i9.1550

Article  PubMed  PubMed Central  Google Scholar 

Yu B, Li C, Sun Y, Wang DW (2021) Insulin treatment is associated with increased mortality in patients with COVID-19 and Type 2 diabetes. Cell Metab 33:65-77.e2. https://doi.org/10.1016/j.cmet.2020.11.014

Article  PubMed  CAS  Google Scholar 

van Niekerk G, van der Merwe M, Engelbrecht AM (2021) Diabetes and susceptibility to infections: implication for COVID-19. Immunology 164:467–475. https://doi.org/10.1111/imm.13383

Article  PubMed  PubMed Central  CAS  Google Scholar 

Govender N, Khaliq OP, Moodley J, Naicker T (2021) Insulin resistance in COVID-19 and diabetes. Prim Care Diabetes 15:629–634. https://doi.org/10.1016/j.pcd.2021.04.004

Article  PubMed  PubMed Central  Google Scholar 

Roberts J, Pritchard AL, Treweeke AT, Rossi AG, Brace N, Cahill P et al (2021) Why Is COVID-19 more severe in patients with diabetes? The role of angiotensin-converting enzyme 2, endothelial dysfunction and the immunoinflammatory system. Front Cardiovasc Med 7:629933. https://doi.org/10.3389/fcvm.2020.629933

Article  PubMed  PubMed Central  CAS  Google Scholar 

Cure E, Cumhur CM (2021) Strong relationship between cholesterol, low-density lipoprotein receptor, Na+/H+ exchanger, and SARS-COV-2: this association may be the cause of death in the patient with COVID-19. Lipids Health Dis 20:179. https://doi.org/10.1186/s12944-021-01607-5

Article  PubMed  PubMed Central  CAS  Google Scholar 

Yacoub R, Campbell KN (2015) Inhibition of RAS in diabetic nephropathy. Int J Nephrol Renovasc Dis 8:29–40. https://doi.org/10.2147/IJNRD.S37893

Article  PubMed  PubMed Central  Google Scholar 

Wilcox CS (2020) Antihypertensive and renal mechanisms of SGLT2 (sodium-glucose linked transporter 2) inhibitors. Hypertension 75:894–901. https://doi.org/10.1161/HYPERTENSIONAHA.119.11684

Article  PubMed  CAS  Google Scholar 

Huot SJ, Aronson PS (1991) Na(+)-H+ exchanger and its role in essential hypertension and diabetes mellitus. Diabetes Care 14:521–535. https://doi.org/10.2337/diacare.14.6.521

Article  PubMed  CAS  Google Scholar 

Fischer Y, Thomas J, Sevilla L, Muñoz P, Becker C, Holman G et al (1997) Insulin-induced recruitment of glucose transporter 4 (GLUT4) and GLUT1 in isolated rat cardiac myocytes. Evidence of the existence of different intracellular GLUT4 vesicle populations. J Biol Chem 272:7085–7092. https://doi.org/10.1074/jbc.272.11.7085

Article  PubMed  CAS  Google Scholar 

Masori M, Hamamoto A, Mawatari K, Harada N, Takahasi A, Nakaya Y (2007) Angiotensin II decreases glucose uptake by downregulation of GLUT1 in the cell membrane of the vascular smooth muscle cell line A10. J Cardiovasc Pharmacol 50:267–273. https://doi.org/10.1097/FJC.0b013e318093ec74

Article  PubMed  CAS  Google Scholar 

Ren Y, Liu Y, Zhang Z, Liu Y, Li K, Zhang L (2022) SNX27-mediated endocytic recycling of GLUT1 is suppressed by SARS-CoV-2 spike, possibly explaining neuromuscular disorders in patients with COVID-19. J Infect S0163–4453(22):00377–00382. https://doi.org/10.1016/j.jinf.2022.06.021

Article  CAS  Google Scholar 

Rosa SC, Gonçalves J, Judas F, Mobasheri A, Lopes C, Mendes AF (2009) Impaired glucose transporter-1 degradation and increased glucose transport and oxidative stress in response to high glucose in chondrocytes from osteoarthritic versus normal human cartilage. Arthritis Res Ther 11:R80. https://doi.org/10.3390/ijms22147605

Article  PubMed  PubMed Central  CAS  Google Scholar 

Togashi K, Wakatsuki S, Furuno A, Tokunaga S, Nagai Y, Araki T (2013) Na+/H+ exchangers induce autophagy in neurons and inhibit polyglutamine-induced aggregate formation. PLoS One 8:e81313. https://doi.org/10.1371/journal.pone.0081313

Article  PubMed  PubMed Central  CAS  Google Scholar 

Leão LL, Tangen G, Barca ML, Engedal K, Santos SHS, Machado FSM, de Paula AMB, Monteiro-Junior RS (2020) Does hyperglycemia downregulate glucose transporters in the brain? Med Hypotheses 139:109614. https://doi.org/10.1016/j.mehy.2020.109614

Article  PubMed  CAS  Google Scholar 

Russell RR 3rd, Yin R, Caplan MJ, Hu X, Ren J, Shulman GI et al (1998) Additive effects of hyperinsulinemia and ischemia on myocardial GLUT1 and GLUT4 translocation in vivo. Circulation 98(20):2180–2186. https://doi.org/10.1161/01.cir.98.20.2180

Article  PubMed  CAS  Google Scholar 

Bielka W, Przezak A, Pawlik A (2021) Therapy of Type 2 diabetes in patients with SARS-CoV-2 infection. Int J Mol Sci 22:7605. https://doi.org/10.3390/ijms22147605

Article  PubMed  PubMed Central  CAS  Google Scholar 

Kim J, Lee HY, Ahn J, Hyun M, Lee I, Min KJ et al (2016) NHX-5, an endosomal Na+/H+ exchanger, is associated with metformin action. J Biol Chem 291:18591–18599. https://doi.org/10.1074/jbc.C116.744037

Article  PubMed  PubMed Central  CAS  Google Scholar 

Packer M (2017) Activation and inhibition of sodium-hydrogen exchanger is a mechanism that links the pathophysiology and treatment of diabetes mellitus with that of heart failure. Circulation 136:1548–1559. https://doi.org/10.1161/CIRCULATIONAHA.117.030418

Article  PubMed  CAS  Google Scholar 

Ventura-López C, Cervantes-Luevano K, Aguirre-Sánchez JS, Flores-Caballero JC, Alvarez-Delgado C, Bernaldez-Sarabia J et al (2022) Treatment with metformin glycinate reduces SARS-CoV-2 viral load: an in vitro model and randomized, double-blind, Phase IIb clinical trial. Biomed Pharmacother 152:113223. https://doi.org/10.1016/j.biopha.2022.113223

Article  PubMed  PubMed Central  CAS  Google Scholar 

Ganesh A, Randall MD (2022) Does metformin affect outcomes in COVID-19 patients with new or pre-existing diabetes mellitus? A systematic review and meta-analysis. Br J Clin Pharmacol 88:2642–2656. https://doi.org/10.1111/bcp.15258

Article  PubMed  CAS  Google Scholar 

Brandes J, Zobel I, Rohmann N, Schlicht K, Geisler C, Hartmann K et al (2022) Dipeptidylpeptidase (DPP)-4 inhibitor therapy increases circulating levels of anti-inflammatory soluble frizzle receptor protein (sFRP)-5 which is decreased in severe COVID-19 disease. Sci Rep 12:14935. https://doi.org/10.1038/s41598-022-18354-x

Article  PubMed  PubMed Central  CAS  Google Scholar 

Moustafa DA, Imran Z, Ismail R, Rayan M, Gadeau AP, Eldassouki H et al (2022) Evaluating the effects of sodium glucose co-transporter-2 inhibitors from a renin-angiotensin-aldosterone system perspective in patients infected with COVID-19: contextualizing findings from the dapagliflozin in respiratory failure in patients with COVID-19 study. Mol Biol Rep 49:2321–2324. https://doi.org/10.1007/s11033-022-07183-w

Article  PubMed  PubMed Central  CAS  Google Scholar